Orange Book product · Generic (ANDA)
CARBIDOPA
CARBIDOPA
At a glance
Mar 10, 2014
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 10, 2014
12 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
CARBIDOPA
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 203261
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARBIDOPA
- —LODOSYNBrand (NDA)
NDA 017830 · ATON
- 2023CARBIDOPAGeneric (ANDA)
ANDA 217961 · REGCON HOLDINGS
- 2019CARBIDOPAGeneric (ANDA)
ANDA 211055 · AUROBINDO PHARMA
- 2018CARBIDOPAGeneric (ANDA)
ANDA 209910 · ZYDUS PHARMS
- 2017CARBIDOPAGeneric (ANDA)
ANDA 204763 · NOVEL LABS INC
- 2016CARBIDOPAGeneric (ANDA)
ANDA 205304 · EDENBRIDGE PHARMS
- 2016CARBIDOPAGeneric (ANDA)
ANDA 204291 · ALVOGEN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
